104 results on '"Pantarotto, Jason"'
Search Results
2. Clinical Specialist Radiation Therapist in Palliative Radiation Therapy: Report of an Orientation, Training, and Support Program
3. Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
4. Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers
5. Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes
6. Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer
7. Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program
8. Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer
9. Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus
10. Pretreatment [18F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status
11. Ablative vs. Non-Ablative Radiotherapy in Palliating Locally Advanced Pancreatic Cancer: A Single Institution Experience and a Systematic Review of the Literature.
12. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1–3 metastases
13. Ontario Health-Cancer Care Ontario Re-Irradiation Symposium Webinar: A Provincial Initiative to Enhance Quality and Safety in Radiation Treatment.
14. Inferring Positions of Tumor and Nodes in Stage III Lung Cancer From Multiple Anatomical Surrogates Using Four-Dimensional Computed Tomography
15. Role of Adaptive Radiotherapy During Concomitant Chemoradiotherapy for Lung Cancer: Analysis of Data From a Prospective Clinical Trial
16. Motion Analysis of 100 Mediastinal Lymph Nodes: Potential Pitfalls in Treatment Planning and Adaptive Strategies
17. 297 Population Analysis of SABR/SRS for the Treatment of Metastatic Cancer in a Jurisdiction of 15 Million People
18. 302 Health Care System Factors Associated with Receipt of Treatment and with Treatment Intent in Stage Iii Non-Small Cell Lung Cancer: A Population-Based Study in Ontario
19. Breast metastasis from primary lung cancer and its association with ablative radiotherapy: A case report
20. Cancer Clinic Redesign: Opportunities for Resource Optimization.
21. A Clinical Consensus Approach to Developing a New Funding Model for Radiation Services in Ontario.
22. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy
23. Developing Radiation Treatment Protocols to Support the Transition to a Quality Based Procedure
24. Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy.
25. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT) : an open-label, phase 3, randomised, superiority trial
26. Adrenal oligometastasis cured with stereotactic ablative radiotherapy
27. 25 Stereotactic Body Radiation Treatment of Synchronous Early Stage Non-Small Cell Lung Cancers
28. 113 Outcome Comparison Between Early Stage Adenocarcinoma and Squamous Cell Carcinoma Lung Cancers Treated with Stereotactic Body Radiation Therapy
29. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
30. Mo1301 NOVEL PLATINUM FIDUCIAL SEEDS MADE IN HOUSE AND WIRE PUSH DELIVERY METHOD
31. Mo1307 HOW GOOD IS EUS GUIDED FIDUCIAL PLACEMENT FOR TARGETED CYBERKNIFE RADIOTHERAPY?
32. Radiotherapy for locally advanced lung cancer: Stages iiia and iiib
33. Radiotherapy for locally advanced lung cancer:Stages iiia and iiib
34. Inferring Positions of Tumor and Nodes in Stage III Lung Cancer from Multiple Anatomical Surrogates Using 4D CT
35. P1.05-069 Stage II NSCLC Treated with Non-Surgical Approaches: A Multi-Institution Report of Outcomes: Topic: Miscellaneous
36. 236: Validity of Specific Growth Rate in Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy (SBRT)
37. 221: Radiation Dose Mapping of the Stomach in Trimodality Therapy for Esophageal Cancer
38. 102: Treatment Planning During the Pandemic – Did Flexible Work Arrangements Make us More Efficient?
39. Feasibility, detectability and clinical experience with platinum fiducial seeds for MRI/CT fusion and real-time tumor tracking during CyberKnife® stereotactic ablative radiotherapy.
40. Impact of Patient Selection, Disease Progression, and Adverse Events on Esophageal Cancer Outcomes After Trimodality Therapy.
41. 146: COVID-19 Pandemic Impact on Radiation Treatment Delivery Metrics.
42. 149: Do Virtual Ro Consults Expedite Treatment? Another Tale from the COVID-19 Pandemic.
43. Pan-Canadian consensus recommendations for proton beam therapy access in Canada.
44. 114: Quality Assurance of Radiotherapy During the COVID-19 Pandemic: Impact on Peer Review in 14 Regional Cancer Centres Across Ontario.
45. 142: Virtual Care Uptake in Radiation Medicine: Lessons Learned from the COVID-19 Pandemic.
46. 39: Impact of Smoking Status and Pack Year History on Outcomes of Early Stage Non-Small Cell Lung Cancers Treated with Stereotactic Ablative Radiotherapy.
47. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
48. 9: Trends in Radiotherapy Fractionation in Ontario From 2011/12 to 2020/21 for the Major Disease Sites and the Impact of COVID19.
49. Pretreatment [18F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status.
50. Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurements
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.